| Code | Description | Claims | Beneficiaries | Total Paid |
| 36415 |
Collection of venous blood by venipuncture |
39,840 |
35,108 |
$7.39M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
61,026 |
20,186 |
$4.31M |
| 81025 |
|
16,078 |
15,455 |
$3.88M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
50,115 |
46,981 |
$3.74M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25,475 |
22,198 |
$3.16M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,353 |
9,570 |
$2.86M |
| 80053 |
Comprehensive metabolic panel |
29,762 |
26,738 |
$2.61M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,927 |
13,108 |
$2.14M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,779 |
1,764 |
$2.12M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,898 |
9,906 |
$1.92M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
26,132 |
23,221 |
$1.84M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
28,801 |
23,717 |
$1.73M |
| 81003 |
|
17,051 |
12,702 |
$1.68M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,823 |
9,161 |
$1.67M |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
9,021 |
8,754 |
$1.39M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
9,366 |
9,189 |
$1.21M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,897 |
3,863 |
$1.17M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,737 |
1,709 |
$1.14M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,486 |
5,300 |
$943K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,044 |
3,995 |
$936K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,843 |
1,839 |
$933K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
10,053 |
9,335 |
$897K |
| 86850 |
|
6,213 |
5,545 |
$884K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
23,840 |
22,632 |
$796K |
| 88304 |
|
2,254 |
2,245 |
$789K |
| 71046 |
Radiologic examination, chest; 2 views |
15,733 |
15,300 |
$708K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,077 |
12,619 |
$694K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15,757 |
15,319 |
$645K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,824 |
4,610 |
$619K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
8,269 |
2,953 |
$616K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
10,885 |
4,015 |
$587K |
| 84156 |
|
1,622 |
1,444 |
$577K |
| 97161 |
|
8,176 |
8,040 |
$570K |
| 81001 |
|
22,650 |
21,398 |
$465K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13,265 |
12,768 |
$436K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,499 |
2,310 |
$403K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,925 |
3,915 |
$390K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,815 |
13,908 |
$374K |
| 95782 |
|
378 |
378 |
$355K |
| 80069 |
|
4,022 |
2,962 |
$346K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,694 |
4,540 |
$319K |
| 87480 |
|
3,054 |
2,998 |
$299K |
| 54360 |
|
680 |
680 |
$288K |
| 84702 |
|
4,226 |
3,757 |
$282K |
| 85027 |
|
10,842 |
9,897 |
$281K |
| 74018 |
|
4,756 |
4,448 |
$270K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
417 |
416 |
$269K |
| 76770 |
|
1,753 |
1,739 |
$269K |
| 87081 |
|
5,948 |
5,894 |
$269K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,827 |
1,768 |
$268K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
6,091 |
6,039 |
$268K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,011 |
4,523 |
$263K |
| 87070 |
|
1,728 |
1,671 |
$262K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
49,974 |
42,637 |
$252K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,378 |
4,368 |
$250K |
| 87481 |
|
602 |
599 |
$248K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,635 |
5,323 |
$248K |
| 92551 |
|
3,266 |
3,261 |
$246K |
| 87210 |
|
3,379 |
3,267 |
$242K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,026 |
1,927 |
$227K |
| 76830 |
Ultrasound, transvaginal |
1,310 |
1,288 |
$217K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,044 |
2,964 |
$205K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,004 |
8,729 |
$196K |
| 95700 |
|
606 |
595 |
$191K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
885 |
879 |
$190K |
| 86900 |
|
6,832 |
6,111 |
$185K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,988 |
3,980 |
$178K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
299 |
299 |
$177K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,032 |
5,853 |
$171K |
| 87077 |
|
4,556 |
4,427 |
$169K |
| 82657 |
|
216 |
216 |
$168K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
696 |
683 |
$161K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,380 |
2,357 |
$161K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,264 |
3,258 |
$161K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,869 |
12,859 |
$158K |
| 73130 |
|
1,693 |
1,558 |
$158K |
| 80061 |
Lipid panel |
9,358 |
9,283 |
$156K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,793 |
1,425 |
$155K |
| 36416 |
|
1,205 |
1,182 |
$154K |
| G0378 |
Hospital observation service, per hour |
12,650 |
9,461 |
$153K |
| 71045 |
Radiologic examination, chest; single view |
6,712 |
6,292 |
$151K |
| 85018 |
|
2,986 |
2,797 |
$151K |
| 83655 |
|
2,042 |
2,012 |
$133K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,830 |
2,784 |
$131K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
23,776 |
20,780 |
$130K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
1,221 |
1,216 |
$123K |
| 93971 |
|
352 |
344 |
$118K |
| 85347 |
|
440 |
373 |
$118K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
894 |
894 |
$117K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
116 |
114 |
$113K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,403 |
9,298 |
$102K |
| 73630 |
|
1,698 |
1,574 |
$101K |
| 86780 |
|
7,668 |
7,576 |
$97K |
| 73560 |
|
1,681 |
1,539 |
$91K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
8,765 |
8,678 |
$87K |
| 93017 |
|
989 |
987 |
$86K |
| 73030 |
|
1,106 |
1,040 |
$84K |
| 96376 |
|
4,382 |
2,905 |
$84K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,443 |
1,437 |
$82K |
| 73610 |
|
1,073 |
1,012 |
$81K |
| 82565 |
|
423 |
413 |
$80K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,412 |
2,412 |
$79K |
| 93922 |
|
156 |
155 |
$78K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,972 |
1,949 |
$77K |
| 76937 |
|
1,187 |
1,089 |
$77K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,546 |
1,538 |
$72K |
| 97165 |
|
1,323 |
1,306 |
$72K |
| 12011 |
|
295 |
294 |
$69K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,725 |
4,620 |
$69K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,249 |
2,209 |
$67K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,145 |
1,126 |
$64K |
| 95806 |
|
297 |
296 |
$63K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
549 |
544 |
$58K |
| 73110 |
|
719 |
659 |
$58K |
| 72100 |
|
1,044 |
1,029 |
$57K |
| 95811 |
|
151 |
151 |
$53K |
| 54161 |
|
356 |
356 |
$51K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
23,023 |
21,420 |
$48K |
| 72040 |
|
564 |
554 |
$48K |
| 88300 |
|
122 |
122 |
$48K |
| 85610 |
|
6,742 |
5,004 |
$45K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
510 |
505 |
$45K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
236 |
236 |
$44K |
| 73090 |
|
415 |
384 |
$44K |
| 95951 |
|
211 |
93 |
$43K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,629 |
1,617 |
$42K |
| 82043 |
|
2,423 |
2,407 |
$41K |
| 86140 |
|
5,091 |
4,564 |
$40K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,505 |
1,468 |
$38K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
397 |
396 |
$38K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
759 |
741 |
$37K |
| 95957 |
|
423 |
203 |
$35K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,140 |
1,118 |
$35K |
| 80074 |
|
1,162 |
1,152 |
$34K |
| 87428 |
|
275 |
269 |
$33K |
| 71250 |
|
84 |
82 |
$33K |
| 84703 |
|
598 |
587 |
$33K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,409 |
1,664 |
$32K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
79 |
79 |
$32K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,025 |
811 |
$32K |
| 74019 |
|
753 |
741 |
$31K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,444 |
9,281 |
$30K |
| 95813 |
|
109 |
107 |
$30K |
| 80076 |
|
1,936 |
1,882 |
$29K |
| 83735 |
|
13,091 |
10,606 |
$29K |
| 86902 |
|
945 |
776 |
$28K |
| 92523 |
|
353 |
352 |
$28K |
| J3490 |
Unclassified drugs |
6,990 |
5,167 |
$27K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
177 |
175 |
$25K |
| 92526 |
|
391 |
201 |
$25K |
| 73590 |
|
420 |
381 |
$25K |
| 93888 |
|
141 |
141 |
$24K |
| 76536 |
|
189 |
186 |
$24K |
| 82728 |
|
3,260 |
3,095 |
$24K |
| 12001 |
|
122 |
122 |
$24K |
| 82950 |
|
2,668 |
2,651 |
$24K |
| 59025 |
Fetal non-stress test |
714 |
473 |
$24K |
| 97162 |
|
510 |
501 |
$23K |
| 84439 |
|
2,570 |
2,537 |
$23K |
| 76642 |
|
300 |
293 |
$21K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
141 |
140 |
$20K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
421 |
415 |
$19K |
| 94760 |
|
1,306 |
830 |
$18K |
| 70496 |
|
80 |
78 |
$18K |
| 84145 |
|
2,263 |
1,865 |
$18K |
| 76886 |
|
102 |
97 |
$18K |
| 84484 |
|
7,057 |
5,299 |
$18K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,472 |
4,806 |
$17K |
| 73502 |
|
334 |
310 |
$17K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
379 |
355 |
$17K |
| 76376 |
|
42 |
42 |
$17K |
| 93880 |
|
56 |
54 |
$17K |
| 76000 |
|
423 |
410 |
$17K |
| 99215 |
Prolong outpt/office vis |
646 |
561 |
$16K |
| 85014 |
|
653 |
611 |
$16K |
| 76801 |
|
650 |
596 |
$16K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
85 |
84 |
$16K |
| 85660 |
|
755 |
639 |
$16K |
| 87807 |
|
284 |
282 |
$15K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,075 |
896 |
$15K |
| 82330 |
|
415 |
398 |
$15K |
| 42830 |
|
53 |
53 |
$15K |
| A4649 |
Surgical supply; miscellaneous |
175 |
157 |
$15K |
| 88142 |
|
1,494 |
1,489 |
$15K |
| 87631 |
|
1,230 |
1,216 |
$14K |
| 82570 |
|
4,014 |
3,807 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
163 |
163 |
$14K |
| 76818 |
|
444 |
258 |
$14K |
| 99174 |
|
200 |
198 |
$14K |
| 74230 |
|
49 |
49 |
$14K |
| 76870 |
|
66 |
64 |
$13K |
| 77072 |
|
374 |
374 |
$13K |
| 93923 |
|
39 |
37 |
$13K |
| 72141 |
|
12 |
12 |
$12K |
| 90686 |
|
6,389 |
6,373 |
$12K |
| 93970 |
|
40 |
40 |
$12K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13,027 |
12,367 |
$12K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
14,868 |
13,814 |
$11K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,866 |
3,212 |
$11K |
| J2704 |
Injection, propofol, 10 mg |
2,223 |
2,043 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16,135 |
14,614 |
$11K |
| 82550 |
|
1,575 |
1,318 |
$11K |
| 0002A |
|
288 |
288 |
$10K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,533 |
4,104 |
$10K |
| 76885 |
|
64 |
64 |
$10K |
| 73070 |
|
59 |
55 |
$10K |
| 83020 |
|
3,372 |
3,135 |
$9K |
| 83001 |
|
321 |
320 |
$9K |
| S5010 |
5% dextrose and 0.45% normal saline, 1000 ml |
1,452 |
865 |
$8K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
66 |
60 |
$8K |
| 82105 |
|
418 |
415 |
$8K |
| 10060 |
|
38 |
37 |
$8K |
| 70360 |
|
69 |
69 |
$8K |
| 93976 |
|
1,601 |
1,530 |
$8K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
781 |
704 |
$8K |
| 0072A |
|
220 |
219 |
$8K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
387 |
165 |
$7K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
650 |
641 |
$7K |
| 84146 |
|
293 |
290 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
70 |
65 |
$7K |
| 86361 |
|
487 |
481 |
$7K |
| 86706 |
|
393 |
387 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
76 |
76 |
$6K |
| 82272 |
|
132 |
131 |
$6K |
| 90715 |
|
3,602 |
3,572 |
$6K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12,335 |
12,267 |
$6K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
10,698 |
10,422 |
$6K |
| 96367 |
|
174 |
158 |
$6K |
| J1815 |
Injection, insulin, per 5 units |
574 |
267 |
$6K |
| 82805 |
|
381 |
347 |
$6K |
| 82607 |
|
1,316 |
1,305 |
$6K |
| 69209 |
|
52 |
51 |
$5K |
| 86901 |
|
6,842 |
6,115 |
$5K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,517 |
2,872 |
$5K |
| S0315 |
Disease management program; initial assessment and initiation of the program |
146 |
146 |
$5K |
| 82962 |
|
131 |
112 |
$5K |
| 80177 |
|
171 |
156 |
$5K |
| 87040 |
|
2,020 |
1,799 |
$5K |
| 83037 |
|
96 |
96 |
$5K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
541 |
288 |
$5K |
| 86038 |
|
414 |
406 |
$5K |
| 70250 |
|
12 |
12 |
$5K |
| 86592 |
|
342 |
340 |
$5K |
| 85045 |
|
8,179 |
7,061 |
$5K |
| 87205 |
|
1,713 |
1,663 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,075 |
7,237 |
$5K |
| 99188 |
|
1,187 |
1,186 |
$5K |
| 73552 |
|
71 |
67 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
39 |
37 |
$4K |
| 82040 |
|
43 |
43 |
$4K |
| 43762 |
|
27 |
24 |
$4K |
| 73080 |
|
28 |
27 |
$4K |
| 85651 |
|
88 |
80 |
$4K |
| 83540 |
|
2,409 |
2,362 |
$4K |
| 11981 |
|
24 |
24 |
$4K |
| 94664 |
|
1,482 |
1,066 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
61 |
59 |
$4K |
| 90647 |
|
2,372 |
2,372 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,638 |
2,924 |
$3K |
| 99173 |
|
867 |
865 |
$3K |
| 83880 |
|
2,356 |
2,103 |
$3K |
| 92610 |
|
105 |
102 |
$3K |
| 86695 |
|
42 |
39 |
$3K |
| 84132 |
|
368 |
341 |
$3K |
| 84466 |
|
1,887 |
1,849 |
$3K |
| 82670 |
|
83 |
83 |
$3K |
| J2060 |
Injection, lorazepam, 2 mg |
982 |
778 |
$3K |
| 85379 |
|
513 |
505 |
$3K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
470 |
185 |
$3K |
| 74022 |
|
89 |
89 |
$3K |
| 84134 |
|
561 |
541 |
$3K |
| 86803 |
|
4,388 |
4,352 |
$3K |
| 0001A |
|
366 |
365 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15,442 |
15,019 |
$3K |
| 90656 |
|
499 |
499 |
$3K |
| 90670 |
|
2,905 |
2,904 |
$3K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,203 |
1,164 |
$3K |
| 99205 |
Prolong outpt/office vis |
116 |
115 |
$2K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
85 |
85 |
$2K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
272 |
272 |
$2K |
| 97116 |
|
436 |
211 |
$2K |
| 87486 |
|
25 |
25 |
$2K |
| 0071A |
|
315 |
315 |
$2K |
| 90677 |
|
736 |
736 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,217 |
639 |
$2K |
| 72170 |
|
55 |
54 |
$2K |
| 84425 |
|
737 |
727 |
$2K |
| 97113 |
|
30 |
13 |
$2K |
| 76377 |
|
17 |
17 |
$2K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
4,038 |
4,021 |
$2K |
| 97597 |
|
73 |
54 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
105 |
104 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
753 |
633 |
$2K |
| 93297 |
|
12 |
12 |
$2K |
| 86480 |
|
275 |
273 |
$2K |
| 73060 |
|
12 |
12 |
$2K |
| 85730 |
|
3,246 |
2,966 |
$2K |
| 90633 |
|
2,627 |
2,625 |
$2K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
640 |
477 |
$2K |
| 80081 |
|
66 |
66 |
$2K |
| 74240 |
|
12 |
12 |
$2K |
| 83690 |
|
5,970 |
5,648 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,866 |
2,325 |
$2K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
451 |
313 |
$1K |
| 0082A |
|
47 |
47 |
$1K |
| 83516 |
|
341 |
338 |
$1K |
| 85384 |
|
194 |
172 |
$1K |
| 70498 |
|
76 |
76 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,018 |
4,937 |
$1K |
| 87536 |
|
553 |
544 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
29 |
29 |
$1K |
| 74220 |
|
12 |
12 |
$1K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
160 |
157 |
$1K |
| 82077 |
|
490 |
475 |
$993.30 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,889 |
1,550 |
$956.15 |
| J3480 |
Injection, potassium chloride, per 2 meq |
737 |
537 |
$954.64 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,544 |
1,242 |
$931.89 |
| 90651 |
|
1,180 |
1,179 |
$931.48 |
| 84100 |
|
2,299 |
1,750 |
$912.22 |
| 84481 |
|
432 |
432 |
$869.80 |
| 91320 |
|
188 |
188 |
$853.81 |
| 87660 |
|
2,979 |
2,928 |
$820.08 |
| 86580 |
|
52 |
49 |
$813.70 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
218 |
214 |
$812.26 |
| 87340 |
|
3,963 |
3,910 |
$742.28 |
| 83605 |
|
1,229 |
1,104 |
$714.91 |
| 0004A |
|
128 |
128 |
$710.34 |
| 86308 |
|
14 |
14 |
$697.91 |
| 92522 |
|
12 |
12 |
$684.77 |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
235 |
88 |
$672.81 |
| 82784 |
|
597 |
584 |
$660.39 |
| 94644 |
|
745 |
706 |
$634.69 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,111 |
5,986 |
$613.57 |
| 0124A |
|
274 |
274 |
$604.46 |
| 87522 |
Neg quan hep c or qual rna |
126 |
125 |
$581.64 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,353 |
875 |
$559.27 |
| 80143 |
|
70 |
68 |
$551.50 |
| 58300 |
|
12 |
12 |
$550.82 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
333 |
264 |
$531.58 |
| 86364 |
|
134 |
133 |
$516.25 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
30 |
28 |
$498.75 |
| 99383 |
|
12 |
12 |
$482.90 |
| 86920 |
|
1,211 |
1,017 |
$482.59 |
| 86696 |
|
58 |
53 |
$448.45 |
| 86704 |
|
136 |
134 |
$402.18 |
| 83615 |
|
1,116 |
815 |
$378.63 |
| 90707 |
|
564 |
564 |
$367.90 |
| 0054A |
|
134 |
134 |
$360.66 |
| 85652 |
|
2,996 |
2,785 |
$339.84 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
22 |
18 |
$337.66 |
| 87075 |
|
132 |
131 |
$336.68 |
| 36430 |
|
1,114 |
901 |
$336.53 |
| 87186 |
|
3,177 |
3,096 |
$319.66 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,475 |
3,922 |
$317.94 |
| 86762 |
|
1,587 |
1,571 |
$310.80 |
| 82627 |
|
12 |
12 |
$289.77 |
| 90620 |
|
512 |
511 |
$288.88 |
| 99152 |
|
258 |
252 |
$265.67 |
| 82553 |
|
35 |
27 |
$262.80 |
| 0081A |
|
105 |
105 |
$261.45 |
| 86923 |
|
165 |
142 |
$259.47 |
| 90696 |
|
437 |
437 |
$258.04 |
| 84550 |
|
220 |
213 |
$254.32 |
| 88342 |
|
198 |
192 |
$234.30 |
| 82746 |
|
734 |
731 |
$222.39 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
2,304 |
2,273 |
$221.51 |
| 90700 |
|
478 |
478 |
$184.11 |
| 86003 |
|
43 |
41 |
$182.45 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,360 |
1,332 |
$171.30 |
| 0052A |
|
14 |
14 |
$166.10 |
| 90723 |
|
2,423 |
2,423 |
$156.00 |
| 29125 |
|
12 |
12 |
$140.22 |
| 36591 |
|
184 |
148 |
$135.60 |
| 84403 |
|
231 |
230 |
$133.50 |
| 90746 |
|
29 |
29 |
$119.81 |
| 89051 |
|
72 |
69 |
$111.51 |
| 80323 |
|
164 |
163 |
$94.94 |
| 0154A |
|
43 |
43 |
$81.66 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
67 |
65 |
$79.73 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
776 |
549 |
$74.02 |
| 90710 |
|
610 |
610 |
$55.07 |
| 90682 |
|
62 |
61 |
$51.55 |
| 86235 |
|
106 |
97 |
$51.16 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
276 |
263 |
$46.12 |
| 82951 |
|
12 |
12 |
$43.76 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
361 |
324 |
$41.74 |
| 90734 |
|
1,660 |
1,625 |
$39.64 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
16 |
16 |
$37.60 |
| 90681 |
|
1,318 |
1,318 |
$36.00 |
| 86255 |
|
156 |
146 |
$35.71 |
| 86787 |
|
76 |
75 |
$32.14 |
| 82785 |
|
19 |
19 |
$18.68 |
| 84450 |
|
152 |
152 |
$17.87 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
15 |
13 |
$17.62 |
| 86317 |
|
35 |
35 |
$13.67 |
| 82947 |
|
45 |
45 |
$13.19 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
152 |
132 |
$11.49 |
| A9270 |
Non-covered item or service |
1,192 |
618 |
$7.98 |
| 36410 |
|
155 |
144 |
$4.30 |
| 84460 |
|
152 |
152 |
$2.71 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
124 |
124 |
$0.00 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
129 |
129 |
$0.00 |
| 87510 |
|
3,041 |
2,985 |
$0.00 |
| 90716 |
|
549 |
549 |
$0.00 |
| 90732 |
|
54 |
51 |
$0.00 |
| 90480 |
|
338 |
337 |
$0.00 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
243 |
242 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
1,420 |
1,414 |
$0.00 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
77 |
75 |
$0.00 |
| 88307 |
|
26 |
26 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
161 |
158 |
$0.00 |
| 95716 |
|
204 |
168 |
$0.00 |
| 86921 |
|
138 |
114 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
54 |
52 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
317 |
316 |
$0.00 |
| 83002 |
|
184 |
183 |
$0.00 |
| 86160 |
|
297 |
279 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
158 |
117 |
$0.00 |
| 70491 |
|
13 |
13 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
150 |
143 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
66 |
54 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
41 |
37 |
$0.00 |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
12 |
12 |
$0.00 |
| 84436 |
|
37 |
37 |
$0.00 |
| 81050 |
|
12 |
12 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
145 |
100 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
56 |
54 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
251 |
221 |
$0.00 |
| 93458 |
|
56 |
55 |
$0.00 |
| C1769 |
Guide wire |
300 |
287 |
$0.00 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
74 |
74 |
$0.00 |
| 31231 |
|
13 |
13 |
$0.00 |
| 86376 |
|
88 |
86 |
$0.00 |
| G0379 |
Direct admission of patient for hospital observation care |
76 |
76 |
$0.00 |
| 87581 |
|
25 |
25 |
$0.00 |
| 0051A |
|
14 |
14 |
$0.00 |
| 86225 |
|
44 |
42 |
$0.00 |
| 88341 |
|
14 |
14 |
$0.00 |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
23 |
12 |
$0.00 |
| 0011A |
|
12 |
12 |
$0.00 |
| 87799 |
|
612 |
607 |
$0.00 |
| 90649 |
|
722 |
722 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
39 |
26 |
$0.00 |
| 86922 |
|
138 |
114 |
$0.00 |
| 90461 |
|
2,778 |
2,775 |
$0.00 |
| 90685 |
|
612 |
612 |
$0.00 |
| 95714 |
|
209 |
152 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
26 |
26 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
220 |
212 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
610 |
606 |
$0.00 |
| 93325 |
|
16 |
16 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
139 |
129 |
$0.00 |
| 87512 |
|
602 |
599 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
46 |
43 |
$0.00 |
| 92611 |
|
13 |
13 |
$0.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
98 |
81 |
$0.00 |
| 80179 |
|
40 |
40 |
$0.00 |
| 84295 |
|
24 |
24 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
26 |
26 |
$0.00 |
| 93750 |
|
49 |
43 |
$0.00 |
| 86200 |
|
49 |
49 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
56 |
42 |
$0.00 |
| 90473 |
|
12 |
12 |
$0.00 |
| 14040 |
|
12 |
12 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
29 |
24 |
$0.00 |
| J1598 |
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg |
66 |
66 |
$0.00 |
| 82977 |
|
14 |
14 |
$0.00 |
| 86431 |
|
159 |
159 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
248 |
248 |
$0.00 |
| 83970 |
|
34 |
34 |
$0.00 |
| 82610 |
|
12 |
12 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
21 |
12 |
$0.00 |
| 90662 |
|
20 |
18 |
$0.00 |
| 94645 |
|
41 |
41 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
16 |
16 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
25 |
25 |
$0.00 |
| 87641 |
|
13 |
13 |
$0.00 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
45 |
16 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
22 |
18 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
39 |
34 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
15 |
14 |
$0.00 |
| 76857 |
|
12 |
12 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
13 |
13 |
$0.00 |
| 82248 |
|
13 |
13 |
$0.00 |
| 84590 |
|
14 |
14 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
25 |
25 |
$0.00 |